X-13709340-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000464506.2(RAB9A):c.594A>T(p.Ser198Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00586 in 1,197,161 control chromosomes in the GnomAD database, including 14 homozygotes. There are 2,357 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0054 ( 0 hom., 170 hem., cov: 23)
Exomes 𝑓: 0.0059 ( 14 hom. 2187 hem. )
Consequence
RAB9A
ENST00000464506.2 synonymous
ENST00000464506.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.842
Genes affected
RAB9A (HGNC:9792): (RAB9A, member RAS oncogene family) Enables GDP binding activity; GTP binding activity; and GTPase activity. Involved in negative regulation by host of symbiont catalytic activity; positive regulation of exocytosis; and regulation of protein localization. Located in late endosome; lysosome; and phagocytic vesicle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant X-13709340-A-T is Benign according to our data. Variant chrX-13709340-A-T is described in ClinVar as [Benign]. Clinvar id is 782175.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.842 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 170 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB9A | NM_004251.5 | c.594A>T | p.Ser198Ser | synonymous_variant | 3/3 | ENST00000464506.2 | NP_004242.1 | |
RAB9A | NM_001195328.2 | c.594A>T | p.Ser198Ser | synonymous_variant | 2/2 | NP_001182257.1 | ||
RAB9A | XM_047442644.1 | c.594A>T | p.Ser198Ser | synonymous_variant | 3/3 | XP_047298600.1 | ||
RAB9A | XM_047442645.1 | c.594A>T | p.Ser198Ser | synonymous_variant | 3/3 | XP_047298601.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB9A | ENST00000464506.2 | c.594A>T | p.Ser198Ser | synonymous_variant | 3/3 | 1 | NM_004251.5 | ENSP00000420127.1 | ||
RAB9A | ENST00000618931.2 | c.594A>T | p.Ser198Ser | synonymous_variant | 2/2 | 2 | ENSP00000480777.1 |
Frequencies
GnomAD3 genomes AF: 0.00541 AC: 607AN: 112195Hom.: 0 Cov.: 23 AF XY: 0.00495 AC XY: 170AN XY: 34365
GnomAD3 genomes
AF:
AC:
607
AN:
112195
Hom.:
Cov.:
23
AF XY:
AC XY:
170
AN XY:
34365
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00492 AC: 843AN: 171403Hom.: 0 AF XY: 0.00514 AC XY: 297AN XY: 57757
GnomAD3 exomes
AF:
AC:
843
AN:
171403
Hom.:
AF XY:
AC XY:
297
AN XY:
57757
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00591 AC: 6410AN: 1084911Hom.: 14 Cov.: 30 AF XY: 0.00619 AC XY: 2187AN XY: 353075
GnomAD4 exome
AF:
AC:
6410
AN:
1084911
Hom.:
Cov.:
30
AF XY:
AC XY:
2187
AN XY:
353075
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00543 AC: 609AN: 112250Hom.: 0 Cov.: 23 AF XY: 0.00494 AC XY: 170AN XY: 34428
GnomAD4 genome
AF:
AC:
609
AN:
112250
Hom.:
Cov.:
23
AF XY:
AC XY:
170
AN XY:
34428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at